Testosterone optimization has become one of the most discussed topics in men's health and longevity, but much of the conversation is dominated by either pharmaceutical marketing (TRT is the answer to everything) or supplement industry noise (tribulus and fenugreek will transform your hormones). The evidence-based picture is more nuanced, more actionable, and more interesting than either of those narratives.

This guide covers the physiology of testosterone in both sexes, what optimal levels actually look like, the lifestyle foundations that move the needle meaningfully, the role of peptides in the testosterone-adjacent axis, and a framework for deciding when lifestyle optimization is sufficient versus when pharmacological intervention merits consideration.

Why Testosterone Matters - In Both Sexes

The testosterone conversation is often framed exclusively around men, which obscures its relevance to roughly half the population. In both biological males and females, testosterone influences:

Energy and vitality: Low testosterone in men and women is associated with fatigue, reduced motivation, and decreased quality of life in multiple observational studies
Cognitive function: Testosterone receptors are present throughout the brain; suboptimal levels are associated with reduced verbal memory, spatial cognition, and executive function
Body composition: Testosterone promotes muscle protein synthesis and inhibits adipogenesis; the body composition changes associated with aging (muscle loss, fat gain) are partially mediated by declining testosterone
Mood and depression: Multiple meta-analyses have found significant associations between hypogonadism and depression, and testosterone supplementation has demonstrated antidepressant effects in some populations
Bone density: Testosterone (and its aromatization to estradiol) is a primary driver of bone mineral density maintenance in both sexes
Cardiovascular health: The relationship is complex, but low testosterone in men is associated with increased cardiovascular risk in large epidemiological datasets

Reference Ranges vs. Optimal Ranges

Laboratory reference ranges are population-derived - they reflect the distribution of values in the tested population, which includes a large proportion of sedentary, overweight, suboptimally-sleeping adults. "Normal" by reference range is not the same as "optimal" by health and performance outcomes.

Biomarker	Lab Reference Range (Male)	Functional Optimal Range (Male)	Notes
Total Testosterone	300-1000 ng/dL	600-900 ng/dL	Upper half of reference; many men feel best here
Free Testosterone	5-25 pg/mL	15-25 pg/mL	Bioavailable fraction; often more clinically relevant than total
SHBG	10-57 nmol/L	20-40 nmol/L	High SHBG binds T, reducing free fraction; low SHBG increases metabolic risk
Estradiol (E2)	10-40 pg/mL	20-35 pg/mL	Critical for bone, mood, libido even in men; too low = problems
LH	1.7-8.6 mIU/mL	4-8 mIU/mL	Upstream signal; low LH with low T indicates secondary hypogonadism

Lifestyle Foundations That Actually Work

Before considering any pharmacological intervention, the lifestyle variables below have robust evidence for meaningful testosterone impact. Each is capable of moving testosterone by 10-30% in individuals who are currently suboptimal in that domain.

Sleep - The Single Biggest Lever

The majority of daily testosterone production occurs during sleep, particularly during slow-wave sleep (SWS). Sleep restriction studies are unequivocal: restricting healthy young men to 5 hours of sleep for one week reduces daytime testosterone by 10-15%. Prioritizing 7-9 hours of sleep in a dark, cool environment (65-68F / 18-20C) is the highest-leverage testosterone intervention available and costs nothing.

Resistance Training

Compound resistance training (squat, deadlift, bench press, rows) acutely elevates testosterone and chronically maintains testicular sensitivity to LH stimulation. Frequency matters: 3-4 sessions per week targeting major muscle groups outperforms both lower and higher frequencies for hormonal optimization. Overtraining (insufficient recovery relative to training volume) can suppress testosterone through cortisol-mediated hypothalamic-pituitary axis suppression.

Body Composition

Adipose tissue is an endocrine organ that aromatizes testosterone to estradiol via aromatase enzyme activity. Higher body fat = higher aromatase activity = lower free testosterone at any given total testosterone production rate. Additionally, obesity is associated with reduced LH pulsatility and Leydig cell sensitivity. The relationship is bidirectional: low testosterone promotes fat gain, and fat gain further suppresses testosterone.

Target: 12-18% body fat for men (15-25% for women) represents the range associated with optimal hormonal profiles in most research.

Micronutrient Optimization

Nutrient	Role in Testosterone	Evidence Quality	Target Level
Zinc	Required cofactor for LH production and testosterone synthesis; deficiency directly impairs both	Strong	Serum zinc 80-120 mcg/dL; supplement 15-30 mg/day if deficient
Vitamin D3	VDR receptors in Leydig cells; D3 supplementation in deficient men raises testosterone in RCTs	Moderate-strong	25-OH-D: 50-80 ng/mL; 4000-6000 IU/day typical maintenance dose
Magnesium	Reduces SHBG binding affinity, increasing free testosterone fraction; RCT evidence in athletes	Moderate	Magnesium glycinate or threonate 400 mg/day before sleep
Boron	Reduces SHBG in short-term RCTs; modest but consistent effect at 10 mg/day	Moderate	10 mg/day supplemental boron

Peptides and the Testosterone Axis

Several peptides have documented or plausible effects on testosterone-adjacent pathways. Unlike lifestyle interventions, their use requires more careful consideration of risk-benefit.

Kisspeptin-10

Kisspeptin is the upstream neuropeptide that triggers GnRH release from the hypothalamus, which in turn drives LH secretion, which stimulates testicular testosterone production. Exogenous Kisspeptin-10 administration has been shown to significantly elevate LH and testosterone in healthy men in multiple published studies, including research from Imperial College London. It acts at the apex of the HPT axis and may be particularly relevant for men with secondary hypogonadism (low T with low-normal LH), where the primary issue is insufficient upstream signaling.

GH-Axis Peptides (Ipamorelin, CJC-1295)

GH and IGF-1 have indirect testosterone-supportive effects through multiple pathways, including enhanced Leydig cell sensitivity and improved body composition (reduced aromatase activity). GH optimization via peptides does not directly raise testosterone, but it operates in complementary territory and may produce synergistic effects on body composition and recovery.

What Does Not Work

The supplement industry sells dozens of products marketed as "testosterone boosters." The evidence-based verdict on the most common ingredients:

Tribulus terrestris: Multiple RCTs show no effect on testosterone in healthy men. No credible mechanism.
Ashwagandha: Some evidence for cortisol reduction which may modestly support T in chronically stressed individuals. Effect size is small. Not a testosterone booster per se.
Fenugreek: Marginal and inconsistent evidence. Not recommended as a primary intervention.
D-Aspartic Acid: One small positive study; subsequent replication failed. Evidence does not support use.

Monitoring Protocol

For anyone optimizing testosterone with or without pharmacological support, a consistent monitoring protocol is essential:

Test frequency: Every 8-12 weeks when actively changing protocols; every 6 months for stable maintenance
Draw timing: Morning (7-9 AM), fasting, consistent time across measurements (testosterone follows a circadian rhythm with morning peak)
Baseline panel: Total T, free T (calculated or direct), SHBG, estradiol, LH, FSH, PSA (men 40+), CBC, CMP
Ongoing monitoring: Total T, free T, estradiol, hematocrit (if on TRT - polycythemia risk)

TRT vs. Peptide Approach: A Framework

Scenario	Recommended Approach
Total T 400-600 ng/dL, normal LH, suboptimal lifestyle	Lifestyle optimization first; reassess in 90 days
Total T 300-450 ng/dL, normal LH, lifestyle already optimized	Consider Kisspeptin-10 or Enclomiphene (SERM); consult physician
Total T below 300 ng/dL, symptomatic, low LH (secondary hypo)	Medical evaluation; SERMs or TRT depending on fertility goals and physician judgment
Total T below 300 ng/dL, symptomatic, high LH (primary hypo)	TRT likely required; Leydig cells not responding to LH signaling adequately
Total T above 600 ng/dL, symptomatic for low T	Evaluate free T and SHBG; high SHBG may be the issue despite adequate total T

Testosterone optimization is not a single intervention but a stack of lifestyle, nutritional, and (where indicated) pharmacological inputs. The sequence matters: exhaust the high-evidence, low-risk lifestyle interventions before adding complexity. Most men who optimize sleep, body composition, resistance training, and micronutrient status will see meaningful improvements in testosterone and associated outcomes without requiring any pharmaceutical intervention.

Evidence-Based Testosterone Optimization (Beyond TRT)